Choice of maintenance immunosuppressive therapy after renal transplantation is important for graft survival. However, complication may also occur. Venous thromboembolic event with the mTOR inhibitor (mTORi) everolimus is a rare but life-threatening complication. Here we describe a renal transplant recipient who developed pulmonary thromboembolism.
Implication for health policy/practice/research/medical education:
Paying attention to the major side effects of immunosuppressive drugs can be effective in selecting and preventing bad events.
Please cite this paper as: Saddadi F, Fallahkohan M. Everolimus induced pulmonary thromboembolism after kidney transplantation; a case report. J Nephropathol. 2022;11(1):e11. DOI: 10.34172/jnp.2022.11.